Qube Research & Technologies (QRT)
VRTX icon

Qube Research & Technologies (QRT)’s Vertex Pharmaceuticals VRTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.55M Sell
10,200
-15,900
-61% -$7.41M 0.01% 1712
2025
Q4 		$11.8M Buy
26,100
+9,000
+53% +$3.88M 0.01% 1234
2025
Q3 		$6.7M Sell
17,100
-3,500
-17% -$1.46M 0.01% 1567
2025
Q2 		$9.17M Buy
20,600
+10,500
+104% +$4.84M 0.01% 1336
2025
Q1 		$4.9M Sell
10,100
-28,500
-74% -$13.3M 0.01% 1549
2024
Q4 		$15.5M Sell
38,600
-191,700
-83% -$88.9M 0.02% 836
2024
Q3 		$107M Buy
230,300
+79,500
+53% +$38.2M 0.16% 135
2024
Q2 		$70.7M Buy
+150,800
New +$65.5M 0.11% 205
2024
Q1 		– Sell
-26,000
Closed -$10.6M – 4906
2023
Q4 		$10.6M Sell
26,000
-8,600
-25% -$3.18M 0.02% 712
2023
Q3 		$12M Buy
+34,600
New +$12.1M 0.03% 570

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return